Insider Trading & Ownership of Matthew Winton

Location
Boston, MA
Summary
The estimated net worth of Matthew Winton is at least $303,925 dollars as of 13 Feb 2026. Matthew Winton is the COO of Inozyme Pharma, Inc. and owns shares of Inozyme Pharma, Inc. stock worth about $184.7K. Matthew Winton is the Chief Commercial and Business of CervoMed Inc. and owns shares of CervoMed Inc. (CRVO) stock worth about $119.2K.
Signature
/s/ William R. Elder, attorney-in-fact for the Reporting Person
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Matthew Winton and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Key facts

  • Matthew Winton has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $303,925.
  • Recent insider filing activity is available below.

Change

  • Largest disclosed position: Inozyme Pharma, Inc. ($184,675).
  • Past-year value change for that position: .

Research use

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Matthew Winton

INZY Forms 3/4/5

Inozyme Pharma, Inc.

Relationship
Coo
Holdings value
$184,675
Past year net change
Change %
Report period
01 Jul 2025

Insider Transactions Reported by Matthew Winton:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .